Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Change in Accured Expenses for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 34.93% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $805000.0 through Dec 2025, down 47.42% year-over-year, with the annual reading at $805000.0 for FY2025, 47.42% down from the prior year.
  • Change in Accured Expenses hit $1.2 million in Q4 2025 for Camp4 Therapeutics, down from $1.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q4 2024 to a low of -$2.8 million in Q1 2025.
  • Historically, Change in Accured Expenses has averaged $322000.0 across 3 years, with a median of $717000.0 in 2024.
  • Biggest five-year swings in Change in Accured Expenses: soared 227.58% in 2024 and later tumbled 721.88% in 2025.
  • Year by year, Change in Accured Expenses stood at $562000.0 in 2023, then skyrocketed by 227.58% to $1.8 million in 2024, then plummeted by 34.93% to $1.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CAMP at $1.2 million in Q4 2025, $1.4 million in Q3 2025, and $1.0 million in Q2 2025.